Colorado Neurological Institute
Englewood, Colorado 80120
1 studies enrolling now · 38 studies all time
What they study most
Acute Ischemic Stroke, Alzheimer Disease, Anaplastic Astrocytoma, Aneurysmal Subarachnoid Hemorrhage, Brain Cancer, Brain Edema, Brain Tumor, Cerebral Aneurysm, Chronic Cluster Headache, Chronic Migraine, Cluster Headache, Episodic Cluster Headache
Studies at this site
- A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) — Running, not enrolling
- Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support) — Completed
- Framing Eighteen Coils in Cerebral Aneurysms Trial — Completed
- Prospective Huntington At Risk Observational Study — Completed
- A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
- Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
- Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
- A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
- 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
- Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia — Completed
- A Study of Galcanezumab in Participants With Chronic Cluster Headache — Completed
- Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
- A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
- Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping — Completed
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma — Stopped early
- Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache — Completed
- A Study Of Galcanezumab In Participants With Episodic Cluster Headache — Completed
- Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
- Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
- Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
- A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
- The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System — Completed
- Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL) — Completed
- Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early
- A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation — Stopped early
- Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease — Completed
- Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 — Available (expanded access)
- LFP Correlates of Movement Disorders — Status unconfirmed
- Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms — Withdrawn before enrolling
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors — Completed
- Pilot Study of Minocycline in Huntington's Disease — Completed
- Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy — Completed
- Parkinson's Research: The Organized Genetics Initiative — Completed
- Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease — Completed
- Transcranial Ultrasound in Clinical SONothrombolysis — Stopped early
- TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease — Completed
- A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) — Completed